The risk of life-threatening complications increases as iron builds up in the organs

Create infographic with copy below

People with sickle cell disease receiving transfusions had 4.1 hospital stays per year vs. 2.1 for non-transfused patients.

The death rate is 3X higher among people with sickle cell disease and transfusion-dependent thalassemia with transfusional iron overload.

 Based on a study of people who were either currently on or had received regular transfusion therapy and confirmed to have iron overload as defined by a liver iron concentration (LIC) of >10 mg/g dry weight or 3 serum ferritin values that averaged ≥2,000 ng/mL within the previous 12 months. 142 people with thalassemia and 199 people with sickle cell disease who received regular transfusions were included in the study group and 64 people with sickle cell disease who did not receive transfusions were selected as controls. Click here to read the full study.

Iron chelation that is right for you at the right dosing level, removes extra iron from the body and organs to help prevent damage caused by iron overload

Goals of appropriate (right for you) iron chelation therapy

Insert text here...

VISUAL – FPO – to be recreated VISUAL – FPO – to be recreated VISUAL – FPO – to be recreated

You are now leaving
Links to other websites are provided as a resource.
Please be aware that Chiesi Global Rare Diseases
is not responsible for content of those websites.